Safety and Efficacy of AS-3201 in the Treatment of Diabetic Sensorimotor Polyneuropathy

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2004
This is a safety and efficacy trial of ranirestat(AS-3201) which is an aldose reductase inhibitor in patients with diabetic sensorimotor polyneuropathy.
Epistemonikos ID: c9b88aaddbcd27849e96553f3eaf67602d981113
First added on: May 04, 2024